Founded in Vienna in 2017, privately owned pharma& acquires, develops, manufactures, and supplies proven specialty medicines whose availability is important to patients worldwide. With nearly 400 industry experts and operations spanning Europe, the United States, and Canada, the company combines pharmaceutical development with in-house API production and packaging. Its Austrian subsidiary Loba biotech makes the active ingredient for Pegasys®, while pharma& continues expanding its focus on hematology and oncology.
Good Manufacturing Practice (GMP) certificate
United Nations Global Compact
Compliance program
PHARMIG Code of Conduct
Compliance program
GMP
Quality certification
ViatrisFormed in 2020 through the combination of Mylan and Upjohn, Viatris develops and manufactures medicines spanning generics, established brands and innovative therapies. Its global manufacturing and scientific network supports access to treatments across more than 165 countries and territories, with about one billion patients receiving its medicines annually. In Austria, the group includes Viatris Austria GmbH and Arcana Arzneimittel GmbH, with 72 employees and nine European production sites.CANONSBURG, PA
PharmaBlock (USA), IncPharmaBlock (USA), Inc. develops and manufactures active pharmaceutical ingredients and related materials for biotech and pharmaceutical companies, taking projects from synthetic route scouting through process development and GMP production. Its Pennsylvania operation combines process R&D and FDA-registered GMP API manufacturing in West Chester with additional chemistry R&D and laboratory space in Hatfield. The West Chester site occupies a four-acre campus with 30,000 square feet of building space, while the company’s quality system has been ISO 9001 certified since 2019.HATFIELD, PA
Pharmaceutical Manufacturing Research Services, Inc. (PMRS)Founded by Edwin R. Thompson in 1994, privately held PMRS develops and contract-manufactures pharmaceutical products from clinical supply through commercial production, with analytical and quality support under one roof. The Horsham company has grown from six employees to about 30 and has completed more than 550 projects, supporting four NDA-approved commercial products, an internationally approved product, and developmental drugs. Its 130,000-square-foot custom facility and hands-on, cross-functional staff reflect a model in which every team member is involved in each project.HORSHAM, PA
STI Pharma, LLCFounded in 2008 by industry executive Anup Dam, privately owned STI Pharma develops, licenses, acquires and commercializes generic medicines. The company manages product development and regulatory support in-house, while its commercial products are made at FDA-registered partner facilities and distributed across the United States and its territories. STI is particularly active in specialty and injectable generics, including recent launches such as thiotepa and isoproterenol hydrochloride.NEWTOWN, PA